Researchers tested VER-01, an experimental cannabis extract, on adults with persistent lower back pain. Patients reported notable reductions in pain scores over several months. Unlike smoking cannabis, VER-01 delivers controlled doses that minimize addiction and severe side effects. Chronic lower back pain affects over 619 million people worldwide and remains the leading cause of disability. Existing treatments, including opioids and NSAIDs like ibuprofen, either risk addiction or cause long-term health problems. Patients often lack effective and safe alternatives, creating urgent demand for new therapies.
Clinical Trial Shows Significant Relief
The study enrolled 820 adults whose pain did not respond to non-opioid medications. Researchers divided participants into two groups: one received VER-01, and the other received a placebo. Patients rated their pain from 0 to 10, with 10 representing extreme pain. After three months, VER-01 users reported a 1.9-point reduction, while the placebo group reported only 0.6 points. During a six-month extension, VER-01 patients improved further, dropping another 1.1 points on the scale. They also experienced better sleep and enhanced physical function. The results, published in Nature Medicine, suggest that VER-01 could become a viable treatment for chronic pain.
Safety and Distinction from Recreational Cannabis
VER-01 contains 2.5 milligrams of THC per dose, along with other plant compounds. Patients mainly experienced mild dizziness, nausea, or temporary sleepiness. Researchers observed no drug abuse or dependence. Experts emphasize that VER-01 differs entirely from smoking cannabis. Jan Vollert compared them to eating hazelnuts versus Nutella: both share a base, but effects differ completely. Patients should not self-medicate with cannabis for chronic pain, he warned. Researchers plan additional trials comparing VER-01 directly with opioids, aiming to confirm its safety and effectiveness for long-term use.
VER-01 could transform chronic back pain treatment, offering relief without addiction risks and providing hope for millions worldwide.
